165 related articles for article (PubMed ID: 26173835)
1. Extended matched intrauterine transfusions reduce maternal Duffy, Kidd, and S antibody formation.
Schonewille H; Prinsen-Zander KJ; Reijnart M; van de Watering L; Zwaginga JJ; Meerman RH; van Kamp IL; Brand A
Transfusion; 2015 Dec; 55(12):2912-9; quiz 2911. PubMed ID: 26173835
[TBL] [Abstract][Full Text] [Related]
2. High anti-HLA response in women exposed to intrauterine transfusions for severe alloimmune hemolytic disease is associated with mother-child HLA triplet mismatches, high anti-D titer, and new red blood cell antibody formation.
Verduin EP; Schonewille H; Brand A; Haasnoot GW; Claas FH; Lindenburg IT; Lopriore E; Oepkes D; Roelen DL; Doxiadis II
Transfusion; 2013 May; 53(5):939-47. PubMed ID: 22924899
[TBL] [Abstract][Full Text] [Related]
3. High additional maternal red cell alloimmunization after Rhesus- and K-matched intrauterine intravascular transfusions for hemolytic disease of the fetus.
Schonewille H; Klumper FJ; van de Watering LM; Kanhai HH; Brand A
Am J Obstet Gynecol; 2007 Feb; 196(2):143.e1-6. PubMed ID: 17306657
[TBL] [Abstract][Full Text] [Related]
4. Duffy and Kidd blood group antigens: minor histocompatibility antigens involved in renal allograft rejection?
Lerut E; Van Damme B; Noizat-Pirenne F; Emonds MP; Rouger P; Vanrenterghem Y; Pirenne J; Ansart-Pirenne H
Transfusion; 2007 Jan; 47(1):28-40. PubMed ID: 17207227
[TBL] [Abstract][Full Text] [Related]
5. Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands.
Koelewijn JM; Vrijkotte TG; van der Schoot CE; Bonsel GJ; de Haas M
Transfusion; 2008 May; 48(5):941-52. PubMed ID: 18248570
[TBL] [Abstract][Full Text] [Related]
6. Induction of additional red cell alloantibodies after intrauterine transfusions.
Viëtor HE; Kanhai HH; Brand A
Transfusion; 1994; 34(11):970-4. PubMed ID: 7974705
[TBL] [Abstract][Full Text] [Related]
7. Outcome predictors for maternal red blood cell alloimmunisation with anti-K and anti-D managed with intrauterine blood transfusion.
Vlachodimitropoulou E; Garbowski M; Anne Solomon S; Abbasi N; Seaward G; Windrim R; Keunen J; Kelly E; Van Mieghem T; Shehata N; Ryan G
Br J Haematol; 2022 Feb; 196(4):1096-1104. PubMed ID: 34862601
[TBL] [Abstract][Full Text] [Related]
8. Successful management of severe red blood cell alloimmunization in pregnancy with a combination of therapeutic plasma exchange, intravenous immune globulin, and intrauterine transfusion.
Nwogu LC; Moise KJ; Klein KL; Tint H; Castillo B; Bai Y
Transfusion; 2018 Mar; 58(3):677-684. PubMed ID: 29250791
[TBL] [Abstract][Full Text] [Related]
9. Red cell alloimmunisation following intrauterine transfusion and the feasibility of providing extended phenotype-matched red cell units.
Doyle B; Quigley J; Lambert M; Crumlish J; Walsh C; Adshead S; Woolfson M; McParland P; Culliton M; Fitzgerald J
Transfus Med; 2014 Oct; 24(5):311-5. PubMed ID: 25229430
[TBL] [Abstract][Full Text] [Related]
10. Successful management of severe hemolytic disease of the fetus due to anti-Jsb using intrauterine transfusions with serial maternal blood donations: a case report and a review of the literature.
Al Riyami AZ; Al Salmani M; Al Hashami S; Al Mahrooqi S; Al Hinai S; Al Balushi H; Al Riyami N; Gowri V; Al Dughaishi T; Al Hosni S; Al-Khabori M; Al-Farsi K; Al Huneini M; Alkindi S
Transfusion; 2014 Jan; 54(1):238-43. PubMed ID: 23829228
[TBL] [Abstract][Full Text] [Related]
11. Does an alloimmune response to strong immunogenic red blood cell antigens enhance a response to weaker antigens?
Schonewille H; Brand A
Transfusion; 2008 May; 48(5):958-63. PubMed ID: 18454736
[TBL] [Abstract][Full Text] [Related]
12. A new preparation method for red blood cells for intrauterine transfusion enabling reduction of donor exposure.
Bontekoe IJ; Scharenberg J; Schonewille H; Zwaginga JJ; Brand A; van der Meer PF; de Korte D
Transfusion; 2015 Jul; 55(7):1693-9. PubMed ID: 25656421
[TBL] [Abstract][Full Text] [Related]
13. Occurrence of five distinct red cell alloantibodies in a renal transplant recipient: Diagnostic and therapeutic implications of minor histocompatibility antigens (Kidd and Duffy) for renal allograft outcome.
Subramaniyan R
APMIS; 2017 Dec; 125(12):1129-1132. PubMed ID: 28960540
[No Abstract] [Full Text] [Related]
14. K, Fy(a), and Jk(a) phenotyping of donor RBCs on microplates.
Diedrich B; Andersson J; Sallander S; Shanwell A
Transfusion; 2001 Oct; 41(10):1263-7. PubMed ID: 11606826
[TBL] [Abstract][Full Text] [Related]
15. Factors associated with persistence of red blood cell antibodies in woman after pregnancies complicated by fetal alloimmune haemolytic disease treated with intrauterine transfusions.
Verduin EP; Brand A; van de Watering LM; Claas FH; Oepkes D; Lopriore E; Doxiadis II; Schonewille H
Br J Haematol; 2015 Feb; 168(3):443-51. PubMed ID: 25244566
[TBL] [Abstract][Full Text] [Related]
16. Fetal hematocrit decrease after repeated intravascular transfusions in alloimmunized pregnancies.
Lobato G; Soncini CS
Arch Gynecol Obstet; 2007 Dec; 276(6):595-9. PubMed ID: 17572904
[TBL] [Abstract][Full Text] [Related]
17. Appearance of maternal anti-JK a antibody following intrauterine transfusions and amniocentesis.
Simpson MB; Pryzbylik JA; Denham MA; Radcliffe JH
Obstet Gynecol; 1978 Nov; 52(5):616-7. PubMed ID: 724181
[TBL] [Abstract][Full Text] [Related]
18. Long-Term follow up after intra-Uterine transfusionS; the LOTUS study.
Verduin EP; Lindenburg IT; Smits-Wintjens VE; van Klink JM; Schonewille H; van Kamp IL; Oepkes D; Walther FJ; Kanhai HH; Doxiadis II; Lopriore E; Brand A
BMC Pregnancy Childbirth; 2010 Dec; 10():77. PubMed ID: 21122095
[TBL] [Abstract][Full Text] [Related]
19. Incidence of alloantibody formation after ABO-D or extended matched red blood cell transfusions: a randomized trial (MATCH study).
Schonewille H; Honohan Á; van der Watering LM; Hudig F; Te Boekhorst PA; Koopman-van Gemert AW; Brand A
Transfusion; 2016 Feb; 56(2):311-20. PubMed ID: 26442648
[TBL] [Abstract][Full Text] [Related]
20. High-dose gammaglobulin (IVIG) followed by intrauterine transfusions (IUTs): a new alternative for the treatment of severe fetal hemolytic disease.
Voto LS; Mathet ER; Zapaterio JL; Orti J; Lede RL; Margulies M
J Perinat Med; 1997; 25(1):85-8. PubMed ID: 9085208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
